Nick Curzen
Latest contributions
New evidence for coronary physiology in epicardial disease
20 May 2026 – From EuroPCR 2026
Explore new evidence in coronary physiology related to epicardial disease through analyses of landmark trials and registries. Topics include five-year follow-up data from DEFINE-FLAIR and iFR-SWEDEHEART, complete revascularization in elderly myocardial infarction patients, angiography-derived versus pressure wire assessments, prognostic implications of CT angiography-derived physiology, and the...
Angiography-based physiology in clinical practice
19 May 2026 – From EuroPCR 2026
Investigate the clinical application of angiography-based physiology in coronary artery disease management. This session covers quantitative flow ratio (QFR) guided PCI strategies, risk stratification in chronic coronary syndrome, and prognostic value of angiography-derived indices, offering a wire-free diagnostic approach supported by recent trial data.
Dealing with complex and unique coronary cases
To gain insight on managing difficult and unusual coronary conditions, view these cases on: balloons, drills and shocks, a novel technique to manage large multiple mycotic aneurysms, rota-stenosis, left main longitudinal compression and many more!
RIPCORD 2: influence of routine pressure wire assessment on management strategy of coronary angiography for diagnosis of chest pain - interview with Nick Curzen
29 Aug 2021
Panos Xaplanteris interviews Nick Curzen about this study on FFR-guided assessment of patients with chest pain when compared with angiographic guidance alone which was presented during ESC Congress 2021.
Author
Author
Why physiology and co-reg is helpful in treating patients with multivessel disease/diffused disease
20 May 2021 – From EuroPCR 2021
Watch this session presented by Sukhjinder Nijjer, Nick Curzen, Rasha Al-Lamee and Sayan Sen in order to learn about the new pressure guide wire OmniWire and workflow enhancement with Azurion and IntraSight, to understand how "interventional physiology" can guide PCI in diffuse, multivessel coronary artery disease, and to learn how...
